MANGALAM

Mangalam Drugs And Organics Ltd.

27.70+0.8 (+3.09%)
21 Aug, 12:00 AM

Annual Reports and Financial Documents

Mangalam Drugs And Organics Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
20132014201520162017201820192020202120222023202420252026
Annual ReportsFY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Quarterly Results
Conference Calls
Presentations

Corporate Announcements and Regulatory Filings

Mangalam Drugs And Organics Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. 17 Aug 2026
    Defaults under Para A sub-paragraph 6 of Schedule III-Subsequent Disclosure
    Intimation of default under Para A sub- paragraph 6 Schedule III-subsequent default
  2. Newspaper Publication13 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper publication for declaration of Un-audited Financial Results (Standalone & Consolidated) for the quarter ended 30th June, 2026
  3. General12 Aug 2026
    Appointment Of Secretarial Auditor Of The Company For Term Of 5 Years Subject To Approval Of Shareholders In Ensuing 53Rd Annaul General Meeting Of The Company
    Appointment of Secretarial Auditor of the Company for term of 5 years from F.Y. 2026-27 to 2030-31 subject to approval of shareholders in ensuing 53rd AGM of the Company
  4. Appointment of Statutory Auditor/s12 Aug 2026
    Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
    Appointment of Statutory Auditor for the period of 5 years subject to approval of sharehoders at ensuing 53rd Annual General meeting.
  5. Outcome of Board Meeting12 Aug 2026
    Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th August, 2026 Interalia For Approval Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended 30Th June, 2026
    Outcome of Board meeting held on 12th August, 2026 interalia for approval of Un-Audited Financial results (Standalone & Consolidated) for the quarter ended 30th June, 2026
  6. General6 Aug 2026
    Intimation Of Resignation Tendered By Ragini Chokshi & Co., Secretarial Auditor Of The Company W.E.F. 4Th August, 2026.
    Intimation pursuant to Regulation 30 read with Schedule III of SEBI (LODR), Regulations, 2015 regarding resiagntion tendered by Ragini Chokshi & Co., Secretarial Auditor of the Company ....
  7. 16 Jul 2026
    Defaults under Para A sub-paragraph 6 of Schedule III-Subsequent Disclosure
    Intimation of subsequent default under Para A sub-paragraph 6 of Schedule III
  8. 15 Jul 2026
    Defaults under Para A sub-paragraph 6 of Schedule III-Subsequent Disclosure
    Intimation of subsequent default made by Company under Para A sub-Paragraph 6 of Schedule III
  9. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201813 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Intimation regarding certificate received from Registrar and Transfer agent under Regukation 74(5) of SEBI (DP) Regulations, 2018
  10. Closure of Trading Window25 Jun 2026
    Closure of Trading Window
    Intimation of closure of trading Window for the period ended 30th June, 2026
  11. Postal Ballot18 Jun 2026
    Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
    Disclosure of Voting Results and Scrutinizers Report for Postal ballot pursuant to Regulation 44 (3) of SEBI LODR, 2025 for re-appointment of Mr. Praveen Saxena as an Independent Director ....
  12. Postal Ballot18 Jun 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
    Disclosure of Voting Results and Scrutinizers Report for Postal ballot pursuant to Regulation 44 (3) of SEBI LODR, 2025 for re-appointment of Mr. Praveen Saxena as an Independent Director ....
  13. 17 Jun 2026
    Defaults under Para A sub-paragraph 6 of Schedule III-Subsequent Disclosure
    Subsequent Disclosure under Regulation 30 part A of Schedule III of SEBI (Listing Obligation and Discloure Requirements) Regulations, 2015 of default of Bank Loan account.
  14. Reg.24(A)-Annual Secretarial Compliance25 May 2026
    Compliances-Reg.24(A)-Annual Secretarial Compliance
    Submission of Annual Secretarial Compliance Report for the period ended 31st March, 2026
  15. Reg.24(A)-Annual Secretarial Compliance25 May 2026
    Compliances-Reg.24(A)-Annual Secretarial Compliance
    Annual Secretarial Compliance Report to be filed for the financial year ended March 31, 2026 as per Regulation 24A of SEBI LODR, 2025.
  16. Newspaper Publication19 May 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Disclosure under Regulation 30 of LODR 2015 for newspaper publication regarding the dispatch of Postal Ballot/ E- Voting seeking shareholders approval.
  17. Postal Ballot18 May 2026
    Dispatch Of Postal Ballot Notice Dated 18.05.2026 By Way Of Remote E- Voting For Taking Shareholders Approval For Reappointment Of Shri Praveen Saxena (Independent Director DIN: 03199264) For Second Term Of 5 Consecutive Years
    Disclosure of notice of postal ballot /E- Voting seeking shareholders approval pursuant to Regulation 30 of SEBI LODR, 2015 . for reappointment of Shri Praveen Saxena as an Independent ....
  18. 16 May 2026
    Defaults under Para A sub-paragraph 6 of Schedule III-Subsequent Disclosure
    Intimation of subsequent default of Bank under Para A sub-paragraph 6 of Schedule III-Subsequent default
  19. Newspaper Publication15 May 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Publication for declaration of Annual Financial Results (Consolidated and Standalone) for the quarter and financial year ended March 31, 2026.
  20. Outcome of Board Meeting14 May 2026
    Board Meeting Outcome for Outcome Of Board Meeting Held On 14Th May, 2026 For Declaration Of Audited Financial Results(Standalone & Consolidated) Of The Company For The Quarter And Year Ended 31St ,March, 2026
    Outcome of Board Meeting held on 14th May 2026 for declaration of Audited Financial Results (Standalone & Consolidated) of the Company for the period ended 31st, March, 2026

Frequently Asked Questions

Where can I download the annual report of Mangalam Drugs And Organics Ltd.?
Annual reports of Mangalam Drugs And Organics Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Mangalam Drugs And Organics Ltd.?
Quarterly earnings results and presentations of Mangalam Drugs And Organics Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Mangalam Drugs And Organics Ltd. publish earnings call transcripts?
Earnings call transcripts of Mangalam Drugs And Organics Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Mangalam Drugs And Organics Ltd.?
Investor presentations and annual day presentations of Mangalam Drugs And Organics Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Mangalam Drugs And Organics Ltd.?
Corporate announcements and regulatory filings of Mangalam Drugs And Organics Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Mangalam Drugs And Organics Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Mangalam Drugs And Organics Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Mangalam Drugs And Organics Ltd.?
The ISIN (International Securities Identification Number) of Mangalam Drugs And Organics Ltd. is INE584F01014. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Mangalam Drugs And Organics Ltd. listed?
Mangalam Drugs And Organics Ltd. is listed on NSE and BSE. The NSE symbol is MANGALAM and the BSE code is -.
Where can I find the shareholding pattern of Mangalam Drugs And Organics Ltd.?
The quarterly shareholding pattern of Mangalam Drugs And Organics Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Mangalam Drugs And Organics Ltd. on Sharpely?
Share price data for Mangalam Drugs And Organics Ltd. is updated as of 21 Aug 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.